New draft guidance published by NICE – the National Institute for Health and Care Excellence recommends the use of the digital technology ‘QbTest’ to help diagnose ADHD in children and young people.
QbTest is a technology that supports objective assessment within the ADHD diagnosis pathway, helping to supplement clinical judgement by measuring a patient’s attention, impulsivity, and motor activity – the three are core symptoms of ADHD.
Developed by company Qbtech, the technology has been rolled out across England from 2020 as part of our Focus ADHD national programme, led by the 15 local networks.
A total of 79 NHS trusts have adopted the technology since 2020 – around three quarters of all trusts that provide ADHD diagnosis – benefiting more than 70,000 young people.
Evaluation of the technology within the East Midlands showed it can help speed up the time from assessment to diagnosis reduced by an average of 153 days.
This increases staff capacity by reducing the number of appointments needed for diagnosis, and since April 2020 an estimated 20,439 NHS appointments have been freed up across England.
This has saved the NHS an estimated £24m, enabling redirection of resources to other parts of the ADHD care pathway, and is a great example of local change having a national impact.
NICE’s draft guidelines on the diagnosis and management of ADHD were published on 16 July; a consultation is underway and comments can be submitted up to 6 August 2024.
Find out more about the Health Innovation Network’s Focus ADHD national programme and meet Tony Doyle, Managing Director of Qbtech in our ‘Meet the Innovator’ interview.
We are delighted to publish the Innovation for Healthcare Inequalities Programme (InHIP) impact and learning report. NHS England’s InHIP programme is a collaboration between the Accelerated Access Collaborative (AAC), NHS England’s National Healthcare Inequalities Improvement Programme and the Health Innovation Network, delivered in partnership with integrated care systems (ICSs). It aims to address local healthcare [...]
Download our Impact Report In 2023-24, as a Network, we delivered national programmes and initiatives that benefitted over 1,228,000 patients, created wealth and health by leveraging £467m through our support to innovators, and worked alongside health and care teams to tackle some of the NHS’s most pressing challenges including cardiovascular disease, patient safety and [...]
We are delighted to welcome Dr Dominique Allwood as the new Chief Executive Officer for Imperial College Health Partners (ICHP). Dominique joins ICHP from neighbouring health innovation network UCLPartners, where she is currently Chief Medical Officer. Her focus is on clinical engagement across the partnership and with the Health Innovation Network Clinical Executives in her [...]
